New patent for Astrazeneca drug TUDORZA PRESSAIR

June 23, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents…

The post New patent for Astrazeneca drug TUDORZA PRESSAIR appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.